Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Up 116.0% in December

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 110,600 shares, an increase of 116.0% from the November 30th total of 51,200 shares. Based on an average daily volume of 20,000 shares, the days-to-cover ratio is currently 5.5 days.

Conduit Pharmaceuticals Stock Down 6.3 %

Conduit Pharmaceuticals stock traded down $0.00 during trading hours on Friday, reaching $0.01. 68,594 shares of the company were exchanged, compared to its average volume of 20,992. Conduit Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.15. The stock has a 50-day moving average of $0.01 and a 200 day moving average of $0.02.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.